Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Shanghai Pharma Faces Media Charges of Accounting Fraud

publication date: May 23, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
The stock price of Shanghai Pharmaceuticals suffered large losses after media reports alleged the company had committed accounting fraud. The reports, carried by the 21st Century Business Herald, said Shanghai Pharma was under investigation for fraudulent accounting of two M&A transactions. Shanghai Pharma denied that it was under investigation by either the Shanghai or the Hong Kong exchange. The company also denied that its accounting was faulty. More details....

Stock Symbols: (SHA: 601607; HK: 2607)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

Bio Taiwan 2015
July 22-26, 2015
Taipei, Taiwan


BioPharm America™ 2015
September 15–17, 2015
Boston, USA

>> More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors